Abstract:The development of pH-sensitive drug delivery nanosystems that present a low drug release at the physiological pH and are able to increase the extent of the release at a lower pH value (like those existent in the interstitial space of solid tumors (pH 6.5) and in the intracellular endolysosomal compartments (pH 5.0)) is very important for an efficient and safe cancer therapy. Laponite (LP) is a synthetic silicate nanoparticle with a nanodisk structure (25 nm in diameter and 0.92 nm in thickness) and negative-charged surface, which can be used for the encapsulation of doxorubicin (DOX, a cationic drug) through electrostatic interactions and exhibit good pH sensitivity in drug delivery. However, the colloidal instability of LP still limits its potential clinical applications. In this study, we demonstrate an elegant strategy to develop stable Laponite-based nanohybrids through the functionalization of its surface with an amphiphile PEG-PLA copolymer by a self-assembly process. The hydrophobic block of PEG-PLA acts as an anchor that binds to the surface of drug-loaded LP nanodisks, maintaining the core structure, whereas the hydrophilic PEG part serves as a protective stealth shell that improves the whole stability of the nanohybrids under physiological conditions. The resulting nanocarriers can effectively load the DOX drug (the encapsulation efficiency is 85%), and display a pH-enhanced drug release behavior in a sustained way. In vitro biological evaluation indicated that the DOX-loaded nanocarriers can be effectively internalized by CAL-72 cells (an osteosarcoma cell line), and exhibit a remarkable higher anticancer cytotoxicity than free DOX. The merits of Laponite/PEG-PLA nanohybrids, such as good cytocompatibility, excellent physiological stability, sustained pH-responsive release properties, and improved anticancer activity, make them a promising platform for the delivery of other therapeutic agents beyond DOX.

pH-sensitive pullulan ramification nano-drug carrier, drug-carrying particle and preparation of pH-sensitive pullulan ramification nano-drug carrier and drug-carrying particle

Ph-Sensitive Pullulan-Based Nanoparticles for Intracellular Drug Delivery

A facile way to fabricate pH-sensitive charge-conversion polymeric nanoparticles with tunable pH conversion point

Dually Responsive Nanoparticles for Drug Delivery Based on Quaternized Chitosan

Drug -driven self-assembly of pH-sensitive nano-vesicles with high loading capacity and anti-tumor efficacy?

Surface charge-reversible polyelectrolyte complex nanoparticles for hepatoma-targeting delivery of doxorubicin.

The design and synthesis of dextran-doxorubicin prodrug-based pH-sensitive drug delivery system for improving chemotherapy efficacy

PH-responsive polyethylene glycol-anticarcinogen conjugate, and synthetic method and application thereof

Hollow Silica–polyelectrolyte Composite Nanoparticles for Controlled Drug Delivery

Amphiphilic polymer-mediated formation of laponite-based nanohybrids with robust stability and pH sensitivity for anticancer drug delivery.

A Rapid Dual-Responsive Releasing Nano-Carrier by Decomposing the Copolymer and Reversing the Core Dissolution

Ph-Sensitive Pullulan-Based Nanoparticle Carrier for Adriamycin to Overcome Drug-Resistance of Cancer Cells.

Charge-conversional and pH-sensitive PEGylated polymeric micelles as efficient nanocarriers for drug delivery.

Research progress of self-assembled nanogel and hybrid hydrogel systems based on pullulan derivatives

Glycyrrhetinic acid-cyclodextrin grafted pullulan nanoparticles loaded doxorubicin as a liver targeted delivery carrier

pH/Redox/Lysozyme-Sensitive Hybrid Nanocarriers With Transformable Size for Multistage Drug Delivery

Nano-Carriers Based On Ph-Sensitive Star-Shaped Copolymers For Drug-Controlled Release

Hollow Mesoporous Silica Nanoparticles Facilitated Drug Delivery Via Cascade Ph Stimuli in Tumor Microenvironment for Tumor Therapy.

Acidity-responsive shell-sheddable camptothecin-based nanofibers for carrier-free cancer drug delivery

Polydopamine-coated Liposomes As Ph-Sensitive Anticancer Drug Carriers

Ph-Responsive Injectable Hydrogels with Mucosal Adhesiveness Based on Chitosan-Grafted-dihydrocaffeic Acid and Oxidized Pullulan for Localized Drug Delivery.